Latest Shareholder Approvals News

SEEK Limited posted a modest 1% rise in revenue for FY2025, while adjusted profit from continuing operations fell 13%, reflecting higher amortisation costs post-platform unification. The company also reacquired Sidekicker, boosting its contingent labour market presence.

Four months after merging with Auswide, MyState reports robust FY25 growth, boosted by operational synergies and strategic investments.

MAC Copper has secured Foreign Investment Review Board approval, satisfying all regulatory conditions for its acquisition by Harmony Gold’s Australian subsidiary. The deal now awaits shareholder votes and court sanction to proceed.

betr Entertainment has withdrawn its Notice of Meeting and cancelled the Selective Buy-Back Meeting following an undertaking with the Takeovers Panel related to its takeover offer for PointsBet. A new combined shareholder meeting will be called soon.

Lake Resources has tapped its At-the-Market facility to raise A$1.575 million, aiming to fund key development stages of its flagship Kachi lithium project in Argentina.

Lake Resources has successfully raised up to A$12 million through a strongly supported placement, bolstering its financial position to advance the Kachi lithium project in Argentina.

Silk Logistics Holdings has completed its acquisition by DP World Australia, with shareholders paid A$2.14 per share and the company set for imminent ASX delisting.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

betr Entertainment Limited has launched a superior all-scrip takeover offer for PointsBet Holdings Limited, valuing PointsBet shares between $1.22 and $1.29 each and aiming to create Australia’s fourth largest online wagering operator. The deal promises substantial cost synergies and strategic growth opportunities.

betr Entertainment Limited has lodged a replacement bidder’s statement enhancing its all-scrip takeover offer for PointsBet Holdings Limited, promising significant cost synergies and a stronger foothold in Australia’s wagering market.